Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Healthcare M&A Spending Spiked in Q1:2019
Spending in the first quarter, totaling $149 billion, beat both the previous quarter (up 239%) and the year-ago time period (up 31%). Three deals had a combined total of $113 billion, accounting for 76% of that spending. Without those three, the first quarter would have ended with approximately $36 billion, which would be 18% lower than the fourth quarter of 2018 ($44 billion) and 68% lower than the first quarter in 2018 ($113 billion). Those big deals began coming early on, beginning with the $74 billion acquisition of biotech biggie Celgene Corp. (NASDAQ: CELG) by Bristol-Myers Squibb (NYSE: BMY) on January 3. The deal put Bristol-Myers deeper into the highly competitive and highly... Read More »
Small World: The Week of International Pharma Deals
Last week, the list of pharmaceutical deals announced also could have served as a geography lesson. Not only was the volume of deals particularly high, accounting for nearly 28% of the week’s total, but it had a diverse list of countries. Beginning in the United States, New York City-based Royalty Pharma, which focuses entirely on acquiring royalty interests in marketed and late-stage biopharmaceutical products, acquired the royalty interest in Indianapolis-based Eli Lilly’s (NYSE: LLY) Emgality from Arteaus Therapeutics (Cambridge, Massachusetts) for $260 million. Advanz Pharma Corp. (ADVZ.TO), a Canadian pharmaceutical company, bought the global rights to two drugs for $33.3... Read More »
Advantia Health Jumps into Digital Health
Advantia Health, a physician medical group focused on women’s health, has acquired telehealth company Pacify. The target developed an app that offers virtual perinatal care for new and expectant mothers. It connects them with consultants and registered nurses to complement in-person visits with OB-GYNs, pediatricians and other physicians. The financial terms of the were not disclosed, but it’s easy to see why Advantia acquired the digital health company. Pacify’s app connects patients with consultants and registered nurses to complement in-person visits with OB-GYNs, pediatricians, and other physicians. This deal combines Advantia’s physical physician practices and... Read More »
Healthcare Dollar Volume Exploded in January
Dollar volume for healthcare deals announced in January was ridiculous, topping $90 billion. We don’t see figures like that in most quarters. The outsized total results from a single deal, of course. Bristol-Myers Squibb’s (NYSE: BMY) $74 billion acquisition of Celgene Corp. (NASDAQ: CELG) made up 81% of the month’s total. Suffice it to say we won’t see many (or any) more months like this. The Hospital sector made a strong contribution, nearly $6 billion. The biggest deal wasn’t a domestic one, however. Australia’s second largest private hospital network, Healthscope Ltd. (ASX: HSO), was acquired by Brookfield Business Partners LP (NYSE: BBU) for approximately $4.1 billion. Two REITs are... Read More »
PE Firms Growing Influence in eHealth
In our 2019 Health Care Services Acquisition Report, Twenty-Fifth Edition, we reported how private equity firms have reshaped healthcare M&A on the services side. However, PE firms and their portfolio companies are also molding the tech sector, particularly in eHealth. In 2017, private equity firms and their portfolio companies accounted for roughly 29% of the 164 digital health deals. In 2018, they accounted for 67 deals, or nearly 33% of the 204 deals reported. Their activity is increasing in both number and volume. In terms of spending volume, private equity firms and portfolio companies accounted for 40% of announced prices for 2017 at roughly $3.69 billion. In 2018, it was nearly... Read More »
Alacare Acquired by Encompass Health Corp.
Encompass Health Corp. (NYSE: EHC) announced it will acquire Alacare Home Health & Hospice for $217 million dollars. That purchase price was about 1.9x the target’s approximate 2018 revenue of $117 million. Founded in 1970, Alacare provides home health, hospice and palliative care, physical rehabilitation, and specialty programs for dementia, cancer, stroke and heart patients. It has a large presence in Alabama, with 23 co-located home health and hospice agencies across the state. The deal will add significant territory to Encompass Health’s service area, adding new markets in Alabama. The company provides facility-and home-based patient care through its 127 hospitals and... Read More »
Health Care M&A Deals, Week Ending April 5, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Novartis AG IFM Tre $310,000,000 eHealth Acquirer Target Price Advantia Health Pacify 4/4/2019 Home Health Care & Hospice Acquirer Target Price Encompass Health Corp. Alacare Home Health & Hospice $217,000,000 BrightStar Care... Read More »
Health Care M&A Deals, Week Ending March 29, 2019
The Health Care M&A Deals Chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Guardant Health, Inc. Bellwether Bio, Inc. N/A AstraZeneca plc Collaboration on trastuzumab deruxtecan $1,350,000,000 eHealth Acquirer Target Price Netmeds Marketplace Pvt. Ltd. KiViHealth $10,000,000 Zyus Life Sciences Inc. Clinical health informatics platform $2,386,020... Read More »
Schweiger Dermatology Group Expands PA Presence with New Deal
Schweiger Dermatology Group, a portfolio company of LLR Partners, is expanding out of its Northeast stronghold with an acquisition of a physician medical group in Pennsylvania. Dermatology & Skin Surgery Center will become a member of the company following the deal and adds 10 physicians to Schweiger’s network. The target physician group provides dermatologic treatments and dermatologic surgery with locations in Exton, Coatesville and Kennett Square, Pennsylvania. With 50 offices and approximately 150 healthcare providers in the New York metro area and Northeastern states, Schweiger Dermatology is looking for new markets to grow. In addition to this deal, the company... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
